Our latest GP survey reveals clear patterns in how Australian doctors are managing menopause with some therapies dominating and others barely used.

The findings highlight important opportunities for pharma to support doctors’ decision-making and improve patient care.

Most Australian GPs encounter rare disease patients without the knowledge or tools to act quickly. AusDoc survey data reveals exactly where the confidence gaps are — and why pharma has a significant and largely untapped opportunity to step in with targeted GP education.

While digital health solutions promise to revolutionise healthcare, not all doctors are convinced. An AusDoc study examining doctors’ views on technology adoption found that those with the most medical experience remain cautious, voicing concerns about security, accuracy, and over-reliance on technology.

As patient interest in wellness continues to rise, GPs are largely supportive of incorporating lifestyle-based interventions into primary care.
However, only about one in three GPs (34%) say they feel fully confident discussing it with patients.

While AI has the potential to revolutionise healthcare, many doctors remain sceptical about its implementation. To foster greater AI adoption in healthcare, companies may benefit from prioritising the following 5 actions.